微信公众号
证券之星APP
| 报告期 | 销售毛利率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2024-09-30 | 39.72% | -7.36% | -2.82% | 23/51 | 35.76% | 南华生物 | 68.03% | 行业排名> |
| 2024-06-30 | 40.87% | -6.42% | -4.26% | 21/51 | 35.89% | 百诚医药 | 68.75% | 行业排名> |
| 2024-03-31 | 42.69% | -5.62% | 0.41% | 17/51 | 35.75% | 百诚医药 | 68.19% | 行业排名> |
| 2023-12-31 | 42.52% | -6.5% | -0.84% | 22/51 | 38.13% | 药康生物 | 67.61% | 行业排名> |
| 2023-09-30 | 42.88% | -9.35% | -1.83% | 22/51 | 39.87% | 药康生物 | 69.14% | 行业排名> |
| 2023-06-30 | 43.68% | -8.52% | -3.44% | 19/51 | 39.77% | 药康生物 | 68.49% | 行业排名> |
| 2023-03-31 | 45.24% | -5.06% | -0.53% | 15/51 | 38.93% | 药康生物 | 69.3% | 行业排名> |
| 2022-12-31 | 45.48% | -5.51% | -3.85% | 16/51 | 40.1% | 药康生物 | 71.38% | 行业排名> |
| 2022-09-30 | 47.3% | -4.12% | -0.93% | 13/51 | 41.1% | 药康生物 | 73.27% | 行业排名> |
| 2022-06-30 | 47.74% | -3.82% | 0.21% | 12/51 | 39.96% | 药康生物 | 75.32% | 行业排名> |
| 2022-03-31 | 47.64% | 0.37% | -1% | 13/51 | 38.57% | 药康生物 | 76.7% | 行业排名> |
| 2021-12-31 | 48.13% | 5.1% | -2.45% | 15/51 | 41.94% | 药康生物 | 74.33% | 行业排名> |
| 2021-09-30 | 49.33% | 7.48% | -0.62% | 12/51 | 43.07% | 南华生物 | 84.53% | 行业排名> |
| 2021-06-30 | 49.64% | 10.16% | 4.58% | 12/51 | 42.6% | 南华生物 | 83.19% | 行业排名> |
| 2021-03-31 | 47.47% | 3.09% | 3.67% | 10/51 | 39.47% | 南华生物 | 83.9% | 行业排名> |
| 2020-12-31 | 45.79% | -11.25% | -0.24% | 21/51 | 38.51% | 成都先导 | 79.36% | 行业排名> |
| 2020-09-30 | 45.9% | -15.12% | 1.85% | 13/51 | 37.76% | 成都先导 | 75.92% | 行业排名> |
| 2020-06-30 | 45.06% | -20.03% | -2.14% | 15/51 | 39.28% | 南华生物 | 78.74% | 行业排名> |
| 2020-03-31 | 46.05% | -21.11% | -10.75% | 11/51 | 33.2% | 成都先导 | 80.82% | 行业排名> |
| 2019-12-31 | 51.59% | -10.77% | -4.59% | 11/51 | 42.94% | 成都先导 | 81.55% | 行业排名> |
| 2019-09-30 | 54.07% | -5.18% | -4.05% | 8/51 | 44.61% | 海特生物 | 84.37% | 行业排名> |
| 2019-06-30 | 56.35% | 0.52% | -3.46% | 9/51 | 45.09% | 海特生物 | 87.74% | 行业排名> |
| 2019-03-31 | 58.37% | -0.04% | 0.96% | 4/51 | 43.51% | 海特生物 | 88.04% | 行业排名> |
| 2018-12-31 | 57.82% | -6.92% | 1.38% | 5/51 | 42.09% | 海特生物 | 92.52% | 行业排名> |
| 2018-09-30 | 57.03% | -12.1% | 1.72% | 4/51 | 43.61% | 海特生物 | 94.18% | 行业排名> |
| 2018-06-30 | 56.06% | -11.13% | -4% | 5/51 | 43.98% | 海特生物 | 94.39% | 行业排名> |
| 2018-03-31 | 58.4% | 2% | -5.99% | 3/51 | 45.58% | 海特生物 | 94.57% | 行业排名> |
| 2017-12-31 | 62.12% | -6.4% | -4.26% | 2/51 | 40.94% | 退市海医 | 87.54% | 行业排名> |
| 2017-09-30 | 64.88% | -4.17% | 2.85% | 2/51 | 44.64% | 海特生物 | 95.31% | 行业排名> |
| 2017-06-30 | 63.08% | -4.9% | -4.94% | 3/51 | 43.6% | 退市海医 | 91.85% | 行业排名> |
| 2016-12-31 | 66.36% | 8.55% | -1.98% | 2/51 | 40.43% | 海特生物 | 95.45% | 行业排名> |
| 2016-09-30 | 67.7% | 2% | 2.06% | 1/51 | 37.08% | 退市海医 | 96.32% | 行业排名> |
| 2016-06-30 | 66.33% | 2% | 8.51% | 1/51 | 33.77% | 海特生物 | 95.35% | 行业排名> |
| 2015-12-31 | 61.13% | 2% | 2% | 2/51 | 37.17% | 退市海医 | 95.27% | 行业排名> |